Article

Retinal endovascular surgery helps those with CRVO, HRVO

Fort Lauderdale, FL-Vitrectomy with retinal vein cannulation and infusion of tissue plasminogen activator (t-PA) is a relatively safe procedure that improves vision in patients with central retinal vein occlusion (CRVO) or hemispheric retinal vein occlusion (HRVO), according to Jeffrey N. Weiss, MD.

Related Videos
Image credit: Ophthalmology Times; Angiogenesis 2025: Encapsulated cell therapy for MacTel shows long-term efficacy in phase 3 trials
Image credit: Ophthalmology Times; Dean McGee Eye Institute resident Ashley Ooms, MD, explores gray area strabismus surgery complications in AUPO poster
© 2025 MJH Life Sciences

All rights reserved.